Study shows rising rates of NET incidence, prevalence and survival

download

A long awaited epidemiological study just published in JAMA Oncology shows progress in the early detection of NETs and improvements in overall survival in the U.S. over many decades.

Check it out here:      Study from Neuroendocrine Tumor Research Foundation

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

NECA partners with Oncidium ahead of World Radiotheranostics Day 2026

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.